Haemophilus B vaccine

Immunogen purified, recombinant mouse granulocyte colony stimulating factor, expressed in E. coli .

Immunogen Peptide with sequence C-TRHEADSSPRGDPES from the internal region of the protein sequence according to NP_006109.2: NP_001018238.

General description HLA-DOA belongs to the HLA class II alpha chain paralogues. HLA-DOA forms a heterodimer with HLA-DOB.

General description HOXA9 is a transcription factor with a central role in both haemopoiesis and leukaemia. High levels of HOXA9 expression in haemopoietic cells is a characteristic feature of acute myeloid leukaemia (AML), and may be sufficient

General description In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally

B.Q.

B.Q.

B.Q.

Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab (anti-TFPI) can be used for haemophilia A/B research.

Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab (anti-TFPI) can be used for haemophilia A/B research.

Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab (anti-TFPI) can be used for haemophilia A/B research.

Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab (anti-TFPI) can be used for haemophilia A/B research.